ASMR

• Multicenter study • Inoperable T1/T2 NSCLC • N=60, mediam age 75 y. • Period: 2003-2005 • F/u: 2 y.

• SBRT • Dose: 45 Gy at 15 Gy/fx • Grade 3 toxicity: 21%

• Local control 96% • OS: 65%; CSS: 80%

Baumann et al. Radiotherapy and Oncology 88 (2008) 359–367